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Imaging Findings in a Case of Mixed
Acinar-Endocrine Carcinoma of the
Pancreas
Mixed acinar-endocrine carcinoma (MAEC) of the pancreas is extremely
uncommon. We report here a rare case of MAEC of the pancreas presenting as
watery diarrhea. This is the first report in the English-language literature that
describes the imaging findings of MAEC of the pancreas, including computed
tomography (CT), magnetic resonance (MR) imaging, and MR cholangiopancre-
atography features.
ixed acinar-endocrine carcinoma (MAEC) of the pancreas is extremely
rare. However, there have been an increasing number of reports of
neoplasms that share many of its characteristic features (1). Because of its
rarity, little is known about the clinical features, pathogenesis, and radiological
features of MAEC. A diagnosis of MAEC is based on pathologic evaluation, including
an analysis of endocrine markers and a histological demonstration of acinar formation
(1, 8). To our knowledge, the radiological findings of MAEC have not been reported in
the English-language literature. Here, we present CT, MRI and histopathologic findings
from a case of MAEC of the pancreas.
CASE REPORT
A 59-year-old woman presented with watery diarrhea that had persisted for two
years. She was referred to our institution with a clinical diagnosis of a vasoactive
intestinal peptide-producing tumor (VIPoma) based on her laboratory results. In
addition, she had been treated for diabetes mellitus for five years. A laboratory
investigation showed increased levels of serum VIP (603 pg/ml; normal range < 20
pg/ml) and serum alkaline phosphatase (162 IU/l; normal range 40-120 IU/l). An
arterial blood gas analysis showed metabolic acidosis with hypokalemia.
On the CT scans, the tail of the pancreas, covering approximately half of the longest
pancreatic axis, was replaced by a heterogeneously hypoattenuating mass-like lesion
which enhanced heterogeneously and had a peripheral enhancing capsule-like
structure. An approximately 1.5-cm hypervascular nodule was visible in the mass
during the hepatic arterial phase (Fig. 1A). No peripancreatic infiltration or direct
invasion of neighboring organs was observed. The main pancreatic duct was not
visible, and no lymphadenopathy was observed. For further evaluation, MR imaging
and MR cholangiopancreatography were performed. The tumor appeared heteroge-
neously hyperintense on T2-weighted MR images, except for the heterogeneously
hypointense nodule located within the mass (Fig. 1B). On contrast-enhanced T1-
weighted MR images during the hepatic arterial phase and portal venous phase, the
tumor showed heterogeneous enhancement with multiple well or poorly enhancing
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Mareas relative to the normal pancreas (Fig. 1C). The nodule
within the mass was also strongly enhanced, while the
peripheral capsule-like structure was not visible. On MR
cholangiopancreatography (TR/TE = 2,050/938), the tumor
appeared hyperintense with multiple hypointense nodular
lesions (Fig. 1D). An endoscopic ultrasonography revealed
a well-defined, homogeneous hypoechoic mass with small
cystic lesions in the pancreas tail. A PET-CT revealed that
the mass showed signs of hypermetabolic activity.
Diagnosis of the mass based on radiological data indicated
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Fig. 1. 59-year-old woman presented with watery diarrhea that had
persisted for two years.
A. On contrast-enhanced axial CT scan during hepatic arterial
phase, tail of pancreas, which is approximately half length of
longest pancreatic axis, was diffusely replaced by heterogeneously
hypo-attenuating mass-like lesion (arrows). Approximately 1.5-cm
hypervascular nodule (open arrow) was also visible in mass.
B. T2-weighted axial MR image indicates that mass (arrows) was
heterogeneously hyperintense compared to normal pancreas,
except for heterogeneously hypointense nodule (open arrow) in
mass.
C. Contrast-enhanced T1-weighted axial MR image during hepatic
arterial phase showed that tumor (arrows) enhances heteroge-
neously with multiple well or poorly enhancing areas relative to
normal pancreas. Nodule (open arrow) in mass was also found to
be well enhanced.
D. MR cholangiopancreatography showed that tumor (arrows) was
hyperintense with multiple hypointense nodular lesions. 
E. Photograph of surgical specimen reveals well-demarcated,
lobulate, soft-tissue mass (arrows) located at tail of pancreas.
Areas of hemorrhage and focal necrosis with cystic change in
mass are evident. S = spleen
Ea possible diffuse pancreatic ductal adenocarcinoma due to
a diffuse heterogeneous mass with an enhancing peripheral
capsule-like structure. An endocrine tumor was also
considered, due to the presence of an enhancing hypervas-
cular nodule, high signal intensity on T2-weighted MR
images, as well as clinical symptoms related to VIP
secretion and an elevated VIP level. 
The patient underwent a partial pancreatectomy along
with a splenectomy. Grossly, the resected tumor measured
8×2.5 cm, and was a well-demarcated, lobulated, soft
mass with septation in the pancreatic tail (Fig. 1E). Also
present were areas of hemorrhage and focal necrosis with
cystic change throughout the tumor. A lymphovascular
invasion was observed without invasion into the spleen.
An immunohistochemical analysis indicated that the tumor
cells were immunoreactive for anti-trypsin (Fig. 1F) and
had Periodic acid-Schiff (PAS)-positive diastase-resistant
cytoplasmic granules, which was consistent with acinar
differentiation. Synaptophysin staining of tumor cells
revealed the positivity supporting endocrine nature of this
tumor (Fig. 1G). Most tumor cells showed immunohisto-
chemically bidirectional differentiation (i.e., presence of
endocrine and acinar cell characteristics, simultaneously).
The tumor had morphologic and immunohistochemical
features of both acinar cell carcinoma and endocrine
tumors. Therefore, the final histopathological diagnosis
was a MAEC.
DISCUSSION
The pancreas is composed of acinar, ductal, and
endocrine cells that are morphologically and functionally
distinct. Pancreatic tumors usually originate from one of
these cell types, most often from ductal cells (2).  However,
it has been reported that pancreatic neoplasms can exhibit
more than one line of cellular differentiation (3). Mixed
exocrine-endocrine neoplasms of the pancreas are rare
tumors, characterized by the association of an exocrine-
ductal or acinar component and a significant endocrine
component that comprises at least one-third to one-half of
the total tumor tissue (2, 4). In a study of 645 pancreatic
tumors, mixed cell type carcinomas were very rare,
representing only 0.2% of all cases (5). MAEC is one of
these mixed neoplasms, exhibiting both acinar and
endocrine differentiation. Although both acinar cell
carcinomas and pancreatic endocrine tumors are distinct
entities, their pathological and morphological appearances
sometimes mimic each other, and their components can be
combined (6). MAEC showed three different combinations:
a tumor with separate acinar and endocrine regions identi-
fiable by light microscopy (collision tumor), a mixture of
endocrine and acinar cells (intermingled tumor), as well as
a tumor with uniform cell population by light microscopy
but with amphicrine features, immunohistochemically (2,
8). The histogenesis of mixed exocrine-endocrine tumors of
the pancreas is still controversial. The co-existence of
exocrine and endocrine elements in these tumors can be
attributed to their common embryologic origin (7).
Although the biologic aggressiveness of MAEC is still
uncertain because of the small number of cases, Klimstra et
al. (8) postulated that the behavior of MAEC may be
similar to that of acinar cell carcinoma. 
To the best of our knowledge, no report focusing on the
radiological findings obtained from an MAEC has been
Chung et al.
380 Korean J Radiol 11(3), May/Jun 2010
Fig. 1. 59-year-old woman presented with watery diarrhea that had persisted for two years.
F. Immunohistochemistry results suggest that tumor cells are immunoactive for anti-trypsin (×200).
G. Photomicrograph of mass with immunohistochemical staining showed that tumor cells are immunoactive for synaptophysin (×100).
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published. In the present case, the MAEC diffusely
involved the pancreatic tail, which was heterogeneously
hypoattenuated compared to the parenchyma of the
normal pancreas, with a peripheral capsule-like enhance-
ment observed on CT. These findings are similar to those
of diffuse pancreatic ductal adenocarcinoma, although the
diffuse morphology of pancreatic ductal adenocarcinoma is
an unusual manifestation that represents only approxi-
mately 5% of all pancreatic ductal adenocarcinomas (9-
11). However, unlike diffuse pancreatic ductal adenocarci-
noma, the tumor appeared heterogeneously hyperintense
on T2-weighted MR images. In addition, well enhancing
portions and a hypervascular nodule were evident on
contrast-enhanced T1-weighted MR images, both of which
could be seen in characteristic pancreatic endocrine tumors
(12, 13). However, some of our findings were uncharacter-
istic of either pancreatic endocrine tumors or acinar cell
carcinomas; namely, diffuse involvement along the long
axis of the pancreas rather than a round mass, a hyperin-
tense mass on MR cholangiopancreatography, i.e. heavily
T2-weighted MR images (12, 14). The typical radiological
findings of acinar cell carcinomas of the pancreas are
solitary, exophytic, oval or round, well-demarcated, and
hypovascular masses with or without cystic areas (14). The
differential diagnosis of a diffuse pancreatic mass also
includes diffuse metastasis to the pancreas and pancreatic
lymphoma. The presence of a peripheral capsule-like
structure, heterogeneous enhancement, including well
enhancing areas and a hypervascular nodule, and high
signal intensity on MR cholangiopancreatography, are
useful for this differential diagnosis (15, 16).
Because MAEC is so rare, its pathogenesis and radiologi-
cal features remain unclear. Therefore, it is difficult to
differentiate MAEC from other pancreatic neoplasms,
including acinar cell carcinomas or endocrine neoplasms,
by radiological evaluation alone. However, MAEC may be
considered when a diffusely involved pancreatic mass
shows heterogeneous hypervascular features and hyperin-
tensity on T2-weighted MR images.
In conclusion, we have described the radiological
findings of a very rare case of MAEC of the pancreas with
diffuse involvement and heterogeneously hypervascular
features.
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